Records containing: Stage III Chronic Lymphocytic Leukemia

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2017-04-05
A Phase 2 Study of Tipifarnib in Large Granular Lymphocyte (LGL) Leukemia
CLINICAL_TRIALS study record update · 2017-04-04
A Genetic Risk-Stratified, Randomized Phase II Study of Four Fludarabine/Antibody Combinations for Patients With Symptomatic, Previously Untreated Chronic Lymphocytic Leukemia
CLINICAL_TRIALS study record update · 2017-03-31
A Pilot Study of Combined Plerixafor + Filgrastim for Mobilization of Peripheral Blood Stem Cells From Normal Donors
CLINICAL_TRIALS study record update · 2017-03-16
A Phase I/II Study of Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 Chimeric Antigen Receptor T-Cells in Patients With Refractory CD19+ B-lineage Leukemia/Lymphoma
CLINICAL_TRIALS study record update · 2017-02-28
Pilot Study of Redirected Autologous T-cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patient With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2017-01-20
A Pilot Study to Evaluate the Potential Efficacy of Lithium Carbonate for Stimulation of Intestinal Recovery In Patients With Acute Graft-versus-host Disease (GVHD)
CLINICAL_TRIALS study record update · 2016-01-28
Clinical Study of Chimeric CD(Cluster of Differentiation)19 Antigen Receptor-modified T Cells in Relapsed and/or Chemotherapy Refractory B-cell Leukemias and Lymphomas
CLINICAL_TRIALS study record update · 2015-11-13
A Pilot Trial of Vorinostat Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease Following Unrelated Donor Hematopoietic Stem Cell Transplantation
CLINICAL_TRIALS study record update · 2015-11-11
A Phase I Feasibility Trial of Cyclophosphamide, Alvocidib (Flavopiridol) and Rituximab (CAR) in Patients With High Risk B-cell CLL/SLL
CLINICAL_TRIALS study record update · 2015-09-29
Pilot Study of Redirected Autologous T Cells Transduced to Express A CD20-Specific Chimeric Immunoreceptor in Patient With Chemotherapy Resistant or Refractory CD20+ Leukemia and Lymphoma
CLINICAL_TRIALS study record update · 2015-08-13
Phase I Trial of Fludarabine and Methoxyamine (TRC102) for Relapsed or Refractory Hematologic Malignancies
CLINICAL_TRIALS study record update · 2015-07-02
Phase I Pharmacokinetic Study of Dasatinib (BMS-354825) (NSC-732517) in Patients With Advanced Malignancies and Varying Levels of Liver Dysfunction
CLINICAL_TRIALS study record update · 2015-06-04
Lenalidomide for the Treatment of CLL Patients With High-Risk Disease
CLINICAL_TRIALS study record update · 2014-10-06
A Phase I-II Trial of Fenretinide (4-HPR) + Rituximab in Patients With B-cell Lymphoma
CLINICAL_TRIALS study record update · 2014-04-10
A Phase II Study of BAY 43-9006 in Relapsed Chronic Lymphocytic Leukemia
CLINICAL_TRIALS study record update · 2014-04-02
A Preliminary Study to Evaluate the Effects of Palifermin in Patients at Risk of Chronic Graft-versus-host Disease
CLINICAL_TRIALS study record update · 2014-01-13
Phase I Clinical Trial of Neem Leaf Extract for the Treatment of Chronic Lymphocytic Leukemia
CLINICAL_TRIALS study record update · 2013-09-30
A Phase 1 Study of Obatoclax Mesylate (GX15-070MS) in Combination With Fludarabine-Based Chemoimmunotherapy in Previously Treated Patients With B-Cell Chronic Lymphocytic Leukemia (B-CLL)
CLINICAL_TRIALS study record update · 2013-08-22
A Phase I Trial of Bendamustine Plus Alemtuzumab for the Treatment of Fludarabine Refractory Chronic Lymphocytic Leukemia
CLINICAL_TRIALS study record update · 2013-07-02
A Phase I Dose-Escalation Study of Flavopiridol (NSC 649890) Administered as a 30 Minute Loading Dose Followed by a 4-Hour Infusion in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Following Cytoreduction With Chemotherapy
CLINICAL_TRIALS study record update · 2013-06-04
A Phase I Study of Flavopiridol, Fludarabine and Rituximab in Indolent B-cell Lymphoproliferative Disorders and Mantle Cell Lymphoma
CLINICAL_TRIALS study record update · 2013-02-08
A Phase I Study of XK469R (NSC 698215) in Patients With Refractory Hematologic Malignancies
CLINICAL_TRIALS study record update · 2013-01-17
A PHASE II STUDY OF FLAVOPIRIDOL (NSC # 649890) IN PATIENTS WITH PREVIOUSLY TREATED BCELL CHRONIC LYMPHOCYTIC LEUKEMIA
CLINICAL_TRIALS study record update · 2012-12-03
A Phase II Study of Fludarabine + Rituximab Induction Followed by Alemtuzumab (Campath-1H, NSC #715969, IND #10864) Administered Subcutaneously as Consolidation in Untreated Patients With B-Cell Chronic Lymphocytic Leukemia
CLINICAL_TRIALS study record update · 2012-08-14
A Phase II Study of Sunitinib Malate in Idiopathic Myelofibrosis